Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
Atsushi IkedaTakahiro KojimaKoji KawaiShiro HinotsuNaoto KeinoKenichiro ShigaHideaki MiyakeYasuyoshi MiyataYutaka EnomotoFumitaka ShimizuSatoshi AnaiHideyasu MatsuyamaChieko SuzukiYusuke KanimotoKeisuke ShigetaSeiji NaitoHideyuki AkazaHiroyuki NishiyamaPublished in: International journal of clinical oncology (2020)
Our data confirmed the effectiveness of two consecutive UroVysion tests in predicting intravesical recurrence after TURBT. Further prospective studies would help determine an appropriate interval for cystoscopy follow-up.